Bank of Montreal
XBIO icon

Bank of Montreal’s Xenetic Biosciences XBIO Stock Holding History

Bank of Montreal’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-83
Closed -$41K – 4917
2018
Q2 		$41K Buy
+83
New +$21.2K ﹤0.01% 3495

Other funds holding XBIO

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

Bank of Montreal's XBIO Position: Q3 2018 in Review

Bank of Montreal sold out of Xenetic Biosciences (XBIO) in Q3 2018, closing a stake of 83 shares — an estimated $41K sold.

Bank of Montreal first reported a position in XBIO in Q2 2018 and held it in 1 quarter. The position peaked at $41K in Q2 2018. 10 funds tracked by Wall St. Rank hold XBIO as of Q3 2018.

  • Bank of Montreal reported no remaining Xenetic Biosciences position as of Q3 2018 after selling out during the quarter.
  • Bank of Montreal sold 83 Xenetic Biosciences shares in Q3 2018, an estimated $41K.
  • Bank of Montreal first reported a position in Xenetic Biosciences in Q2 2018 and held it in 1 quarter.
  • Bank of Montreal's Xenetic Biosciences position peaked at $41K in Q2 2018.
  • 10 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2018.

Based on Bank of Montreal's 13F filing for Q3 2018, filed 12 Oct 2018.